Oxford Vaccine Rollout At the very end of December, UK healthcare regulator the Medicines and Healthcare Products Regulatory ...

The Oxford-AstraZeneca Covid vaccine is being withdrawn worldwide, the company has said, months after the pharmaceutical firm ...

An Oxford company working on cancer vaccines has appointed a former AstraZeneca and Pfizer employee as its new chief medical officer. Biotech firm SpyBiotech has appointed Dr Prakash Bhuyan to the ...

The study is testing a COVID-19 vaccine being developed by AstraZeneca and University of Oxford researchers at various sites, including the United Kingdom, where the adverse event was reported.

AstraZeneca PLC AZN shares inched down 0.99% to £117.80 Friday, on what proved to be an all-around rough trading session for ...

The U.S. Food and Drug Administration said on Friday it has approved AstraZeneca's nasal spray flu vaccine for ...

“Before Jack had his Oxford AstraZeneca Covid-19 injection, he hadn’t had a single day sick from work. He was very rarely unwell. Then suddenly he was not fine. It all happened so quickl ...

Sanofi said on Monday the U.S. Food and Drug Administration has approved a manufacturing line for its and partner AstraZeneca ...

In a report released today, Eric Le Berrigaud from Stifel Nicolaus maintained a Buy rating on AstraZeneca (AZN – Research Report), with a ...

AstraZeneca (AZN – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Sachin Jain from Bank of America Securities maintained a Buy rating on ...

Shares of AstraZeneca PLC AZN inched up 0.35% to £118.98 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the FTSE 100 Index UKX rising 0.91% to 8,328.

The vaccine in question is AstraZeneca (AZ) and the University of Oxford’s two-dose adenovirus vaccine candidate. This approval occurs in the context of an escalating Covid-19 crisis in the UK.